Do Serum Biomarkers Really Measure Breast Cancer?

DSpace/Manakin Repository

Do Serum Biomarkers Really Measure Breast Cancer?

Citable link to this page

. . . . . .

Title: Do Serum Biomarkers Really Measure Breast Cancer?
Author: Mukherjee, Sayan; Yurkovetsky, Zoya; Clyde, Merlise; Marks, Jeffrey R; Lokshin, Anna E; Lo, Joseph Y; Jesneck, Jonathan Lee

Note: Order does not necessarily reflect citation order of authors.

Citation: Jesneck, Jonathan L., Sayan Mukherjee, Zoya Yurkovetsky, Merlise Clyde, Jeffrey R. Marks, Anna E. Lokshin, and Joseph Y. Lo. 2009. Do serum biomarkers really measure breast cancer? BMC Cancer 9: 164.
Full Text & Related Files:
Abstract: Background: Because screening mammography for breast cancer is less effective for premenopausal women, we investigated the feasibility of a diagnostic blood test using serum proteins. Methods: This study used a set of 98 serum proteins and chose diagnostically relevant subsets via various feature-selection techniques. Because of significant noise in the data set, we applied iterated Bayesian model averaging to account for model selection uncertainty and to improve generalization performance. We assessed generalization performance using leave-one-out cross-validation (LOOCV) and receiver operating characteristic (ROC) curve analysis. Results: The classifiers were able to distinguish normal tissue from breast cancer with a classification performance of AUC = 0.82 ± 0.04 with the proteins MIF, MMP-9, and MPO. The classifiers distinguished normal tissue from benign lesions similarly at AUC = 0.80 ± 0.05. However, the serum proteins of benign and malignant lesions were indistinguishable (AUC = 0.55 ± 0.06). The classification tasks of normal vs. cancer and normal vs. benign selected the same top feature: MIF, which suggests that the biomarkers indicated inflammatory response rather than cancer. Conclusion: Overall, the selected serum proteins showed moderate ability for detecting lesions. However, they are probably more indicative of secondary effects such as inflammation rather than specific for malignancy.
Published Version: doi:10.1186/1471-2407-9-164
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696469/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:4728494

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters